Bardia A, Jhaveri K, Im SA, Pernas S, et al. Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01. J Clin Oncol 2024 Sep 12:JCO2400920. doi: 10.1200/JCO.24.00920.
PMID: 39265124